--- title: "AKZA: Q2 2026 saw 2% organic sales growth, margin expansion, and strong merger progress" type: "News" locale: "en" url: "https://longbridge.com/en/news/293502785.md" description: "Organic sales grew 2% in Q2 2026, with margin expansion and adjusted EBITDA up 5% year-over-year. Merger preparations with Axalta are on track, and the company achieved its carbon reduction target four years early. Guidance for 2026 EBITDA and free cash flow remains unchanged.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source." datetime: "2026-07-22T17:03:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293502785.md) - [en](https://longbridge.com/en/news/293502785.md) - [zh-HK](https://longbridge.com/zh-HK/news/293502785.md) generator: "portal-rs" --- # AKZA: Q2 2026 saw 2% organic sales growth, margin expansion, and strong merger progress Organic sales grew 2% in Q2 2026, with margin expansion and adjusted EBITDA up 5% year-over-year. Merger preparations with Axalta are on track, and the company achieved its carbon reduction target four years early. Guidance for 2026 EBITDA and free cash flow remains unchanged. Based on **Disclaimer** This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source. ### Related Stocks - [AXTA.US](https://longbridge.com/en/quote/AXTA.US.md) ## Related News & Research - [AXTA: Record Q2 results with margin gains, robust cash flow, and progress on the AkzoNobel merger](https://longbridge.com/en/news/294050377.md) - [AkzoNobel shareholders back proposed Axalta merger at EGM](https://longbridge.com/en/news/295255426.md) - [Anthropic's IPO: Is Wall Street Ready for a $2 Trillion AI Bet?](https://longbridge.com/en/news/296229187.md) - [AIIR: H1'26 saw resilient revenue and stable Adjusted EBITDA amid disruption, with growth set to accelerate](https://longbridge.com/en/news/296476265.md) - [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**